000250.KQ Loading...

Loading chart...
Top Calls
Feed
Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
Loading...
0 selected
All Content✓
Source feeds
Buzzberg's Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
03:26
Jun 17
Jang Woo-jin Writer 3PRO TV (삼프로TV)
Biopharma offers a contrarian buying opportunity.
Biopharma stocks like Alteogen, Samchundang Pharm, and ABL Bio are showing signs of a turnaround. They offer a contrarian buying opportunity against the consensus of rising interest rates, especially as oil prices have dropped significantly.
000250.KQ 1ST
MED
00:32
Jun 17
Park Byeong-chang Director, MP Partners 3PRO TV (삼프로TV)
Watch Samchundang Pharm for biotech turnaround
Samchundang Pharm's collapse has weighed heavily on KOSDAQ biotech; its potential rebound could signal a biotech recovery, especially with H2 catalysts from global pharma patent expirations accelerating licensing deals.
000250.KQ
MED

About 000250.KQ Analyst Coverage

Buzzberg tracks 000250.KQ across 1 sources. 1 bullish vs 0 bearish calls from 2 analysts. Sentiment: predominantly bullish (50%). 2 total trade ideas tracked. Past 7 days: 1 bullish, 1 watch. Latest voices: Jang Woo-jin, Park Byeong-chang.